133 related articles for article (PubMed ID: 24630433)
1. Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats.
Bortolato M; Bini V; Frau R; Devoto P; Pardu A; Fan Y; Solbrig MV
Eur Neuropsychopharmacol; 2014 Jun; 24(6):974-85. PubMed ID: 24630433
[TBL] [Abstract][Full Text] [Related]
2. Chronic Exposure to WIN55,212-2 During Adolescence Alters Prefrontal Dopamine Turnover and Induces Sensorimotor Deficits in Adult Rats.
Abboussi O; Andaloussi ZL; Chris AD; Taghzouti K
Neurotox Res; 2020 Oct; 38(3):682-690. PubMed ID: 32757167
[TBL] [Abstract][Full Text] [Related]
3. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.
Solbrig MV; Fan Y; Hermanowicz N; Morgese MG; Giuffrida A
Exp Neurol; 2010 Nov; 226(1):231-41. PubMed ID: 20832403
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood.
Jacobs-Brichford E; Manson KF; Roitman JD
Physiol Behav; 2019 Feb; 199():395-404. PubMed ID: 30529340
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
Schneider M; Drews E; Koch M
Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
[TBL] [Abstract][Full Text] [Related]
6. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
8. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.
Verrico CD; Jentsch JD; Roth RH
Synapse; 2003 Jul; 49(1):61-6. PubMed ID: 12710016
[TBL] [Abstract][Full Text] [Related]
9. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
[TBL] [Abstract][Full Text] [Related]
10. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
11. Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats.
Gomez DM; Everett TJ; Hamilton LR; Ranganath A; Cheer JF; Oleson EB
Neuropharmacology; 2021 Jan; 182():108374. PubMed ID: 33115642
[TBL] [Abstract][Full Text] [Related]
12. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Wegener N; Koch M
Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugs.
Tomas-Roig J; Havemann-Reinecke U
Psychoneuroendocrinology; 2019 Apr; 102():1-8. PubMed ID: 30476795
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.
Solbrig MV; Hermanowicz N
J Neurovirol; 2008 May; 14(3):252-60. PubMed ID: 18569459
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine.
Scherma M; Qvist JS; Asok A; Huang SC; Masia P; Deidda M; Wei YB; Soni RK; Fratta W; Fadda P; Kandel ER; Kandel DB; Melas PA
Proc Natl Acad Sci U S A; 2020 May; 117(18):9991-10002. PubMed ID: 32312805
[TBL] [Abstract][Full Text] [Related]
17. Comparing dopaminergic dynamics in the dorsolateral striatum between adolescent and adult rats: Effect of an acute dose of WIN55212-2.
Pérez-Valenzuela E; Castillo-Faúndez R; Fuentealba JA
Brain Res; 2019 Sep; 1719():235-242. PubMed ID: 31181184
[TBL] [Abstract][Full Text] [Related]
18. Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.
Enayatfard L; Rostami F; Nasoohi S; Oryan S; Ahmadiani A; Dargahi L
Neuromolecular Med; 2013 Sep; 15(3):523-35. PubMed ID: 23794089
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.
Gleason KA; Birnbaum SG; Shukla A; Ghose S
Transl Psychiatry; 2012 Nov; 2(11):e199. PubMed ID: 23188199
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.
Pintor A; Tebano MT; Martire A; Grieco R; Galluzzo M; Scattoni ML; Pèzzola A; Coccurello R; Felici F; Cuomo V; Piomelli D; Calamandrei G; Popoli P
Neuropharmacology; 2006 Oct; 51(5):1004-12. PubMed ID: 16895732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
